Phase 2/3 trials of Covid-19 vaccine Sputnik V commence in India

The clinical trials, which are being conducted by JSS Medical Research as the clinical research partner, will be a multicenter and randomized controlled study that will include safety and immunogenicity studies. Dr Reddy’s said it has also partnered with the Biotechnology Industry Research Assistance Council (BIRAC) of the Department of Biotechnology (DBT) for advisory support and for using BIRAC’s clinical trial centres for the vaccine.